Black Rock Inc. Regulus Therapeutics Inc. Transaction History
Black Rock Inc.
- $4.35 Trillion
- Q2 2024
A detailed history of Black Rock Inc. transactions in Regulus Therapeutics Inc. stock. As of the latest transaction made, Black Rock Inc. holds 3,968,857 shares of RGLS stock, worth $32.4 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
3,968,857
Previous 68,031
5733.89%
Holding current value
$32.4 Million
Previous $195,000
3543.08%
% of portfolio
0.0%
Previous 0.0%
Shares
7 transactions
Others Institutions Holding RGLS
# of Institutions
7Shares Held
4.59MCall Options Held
0Put Options Held
25K-
Cvi Holdings, LLC Wilmington, DE401KShares$3.27 Million6.25% of portfolio
-
Nuveen Asset Management, LLC Chicago, IL85.6KShares$698,5120.0% of portfolio
-
Jpmorgan Chase & CO New York, NY74.5KShares$608,0580.0% of portfolio
-
Peak6 Investments LLC Chicago, IL60KShares$489,6000.0% of portfolio
-
Ifp Advisors, Inc0Shares$00.0% of portfolio
About Regulus Therapeutics Inc.
- Ticker RGLS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 14,634,400
- Market Cap $119M
- Description
- Regulus Therapeutics Inc., a clinical stage biopharmaceutical company, engages in the discovery and development of drugs that targets microRNAs to treat a range of diseases in the United States. Its product candidates include RG-012, an anti-miR targeting miR-21 that is in Phase II clinical trial for the treatment of Alport syndrome, a life-thre...